磷丙泊酚二钠的药理学特性及临床应用进展

李曼 ,  张树峰

大连医科大学学报 ›› 2026, Vol. 48 ›› Issue (3) : 270 -274.

PDF (491KB)
大连医科大学学报 ›› 2026, Vol. 48 ›› Issue (3) : 270 -274. DOI: 10.11724/jdmu.2026.03.12
综述

磷丙泊酚二钠的药理学特性及临床应用进展

作者信息 +

Pharmacological characteristic and clinical application progress of fospropofol disodium

Author information +
文章历史 +
PDF (502K)

摘要

磷丙泊酚二钠为丙泊酚前体药物,主要经内皮细胞产生的碱性磷酸酶代谢转换为丙泊酚,进而发挥麻醉镇静作用。磷丙泊酚二钠为水溶性,可降低泵注过程中细菌污染的概率,减轻静脉注射时的疼痛感,且不会引发高脂血症等。此外,其药代动力学稳定,相较于丙泊酚,起效稍慢,作用时间长,镇静深度可预测且可控性好,对呼吸和循环的影响较小。目前已证实,磷丙泊酚二钠可安全用于全身麻醉的诱导与维持、监护下麻醉及 ICU 镇静,尤其适用于老年患者和循环功能不全人群的麻醉。

Abstract

Fospropofol disodium, a prodrug of propofol, is primarily metabolized to propofol via alkaline phosphatase secreted by endothelial cells, thus exerting anesthetic and sedative effects. Fospropofol disodium is water-soluble, which may reduce the risk of bacterial contamination during infusion, alleviate intravenous injection pain, and avoid complications such as hyperlipidemia. Meanwhile, fospropofol disodium has stable pharmacokinetic characteristics. Compared with propofol, it has a slightly slower onset but a longer duration of action, with predictable and well-controllable sedation depth, and milder effects on the respiratory and circulatory systems. Currently, it has been confirmed that fospropofol disodium can be safely used for induction and maintenance of general anesthesia, monitored anesthesia care, and ICU sedation, and is particularly suitable for elderly patients and populations with circulatory insufficiency.

关键词

磷丙泊酚二钠 / 药理学 / 临床应用 / 不良反应

Key words

fospropofol disodium / pharmacology / clinical application / adverse reactions

引用本文

引用格式 ▾
李曼,张树峰. 磷丙泊酚二钠的药理学特性及临床应用进展[J]. 大连医科大学学报, 2026, 48(3): 270-274 DOI:10.11724/jdmu.2026.03.12

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

磷丙泊酚二钠临床应用指导意见专家组. 磷丙泊酚二钠临床应用指导意见[J]. 中华麻醉学杂志, 2023, 43(8): 912-915. DOI: 10.3760/cma.j.cn131073.20230727.00803.

[2]

Wang R, Jiang XJ, Cao QF, et al. Pharmacokinetics and safety of fospropofol disodium for injection in subjects with hepatic impairment compared with healthy matched controls: a prospective cohort study[J]. Drug Des Dev Ther, 2025, 19: 9355-9366. DOI: 10.2147/dDDT.s545798.

[3]

Bengalorkar GM, Bhuvana K, Sarala N, et al. Fospropofol: clinical pharmacology[J]. J Anaesthesiol Clin Pharmacol, 2011, 27(1): 79-83. DOI: 10.1038/clpt.2010.88.

[4]

何涛, 王永徽, 付静文, 等. 血清碱性磷酸酶水平与择期手术患者磷丙泊酚钠起效时间及不良反应发生率的关系分析[J]. 临床合理用药杂志, 2022, 15(33): 50-52. DOI: 10.15887/j.cnki.13-1389/r.2022.33.013.

[5]

Liu R, Luo CZ, Liu J, et al. Efficacy and safety of FospropofolFD compared to propofol when given during the induction of general anaesthesia: a phase II, multi-centre, randomized, parallel-group, active-controlled, double-blind, double-dummy study[J]. Basic Clin Pharmacol Toxicol, 2016, 119(1): 93-100. DOI: 10.1111/bcpt.12552.

[6]

Wu CM, Zhang WS, Liu J, et al. Efficacy and safety of fospropofol disodium for injection in general anesthesia induction for adult patients: a phase 3 trial[J]. Front Pharmacol, 2021, 12: 687894. DOI: 10.3389/fphar.2021.687894.

[7]

Xu YP, Liu Q, Yang Z, et al. Efficacy and safety of fospropofol disodium versus propofol for general anesthesia induction: a systematic review and meta-analysis[J]. Eur J Med Res, 2026, 31(1): 547. DOI: 10.1186/s40001-026-04165-7.

[8]

Cheng LQ, Zhang YL, Leng HX, et al. Fospropofol disodium combined with sufentanil impact on the endotracheal intubation: induced cardiovascular response: a dose-finding study[J]. J Perianesth Nurs, 2025, 40(6): 1527-1534. DOI: 10.1016/j.jopan.2025.02.017.

[9]

刘佳琦. 磷丙泊酚二钠用于全身麻醉诱导与维持的有效性和安全性观察[D]. 合肥: 安徽医科大学, 2024.

[10]

Ding S, Wang ZB, Li CL, et al. Effects of fospropofol disodium and propofol on the postoperative recovery of elderly patients who underwent total hip arthroplasty: a retrospective study[J]. Drug Des Dev Ther, 2025, 19: 2767-2777. DOI: 10.2147/DDDT.S501222.

[11]

张东浩, 李金辉, 班儒孟, 等. 成人择期手术患者全麻诱导和维持中应用磷丙泊酚二钠与丙泊酚的疗效和安全性比较[J]. 吉林大学学报 (医学版), 2025, 51(1): 143-149. DOI: 10.13481/j.1671-587X.20250117.

[12]

李金辉. 磷丙泊酚二钠与丙泊酚用于成人全麻诱导与维持的临床研究[D]. 长春: 吉林大学, 2023.

[13]

Yue FL, Shi XY, Ji RY, et al. Anesthesia effects of different doses of fospropofol disodium for painless colonoscopy diagnosis and treatment[J]. Front Med, 2025, 12: 1562592. DOI: 10.3389/fmed.2025.1562592.

[14]

Zhao Z, Jin XG, Li Y, et al. Efficacy and safety of fospropofol disodium sedation for same-day bidirectional endoscopy in elderly patients: protocol for a prospective, single-center, randomized, double-blind, non-inferiority trial[J]. Front Pharmacol, 2024, 15: 1378081. DOI: 10.3389/fphar.2024.1378081.

[15]

白清海, 张强, 梁亮亮, 等. 磷丙泊酚二钠与丙泊酚用于消化内镜短小手术麻醉的有效性及安全性比较[J]. 临床医学研究与实践, 2025, 10(11): 82-85. DOI: 10.19347/j.cnki.2096-1413.202511021.

[16]

Gurudatt CL. Sedation in intensive care unit patients: assessment and awareness[J]. Indian J Anaesth, 2011, 55(6): 553. DOI: 10.4103/0019-5049.90607.

[17]

Gao XH, Yang XB, Shu HQ, et al. Fospropofol disodium for sedation of postoperative ICU patients: a dose-finding study[J]. Am J Ther, 2024, 31(4): e435-e439. DOI: 10.1097/mjt.0000000000001650.

[18]

Gao XH, Yang XB, Tang Y, et al. Fospropofol disodium versus propofol for long-term sedation during invasive mechanical ventilation: a pilot randomized clinical trial[J]. J Clin Anesth, 2024, 95: 111442. DOI: 10.1016/j.jclinane.2024.111442.

[19]

Gao XH, Gao CG, Fang XZ, et al. Fospropofol disodium versus Propofol for deep sedation in critically ill patients: a randomized pilot study[J]. BMC Anesthesiol, 2025, 25(1): 166. DOI: 10.1186/s12871-025-03025-x.

[20]

Lu ZH, Zheng H, Chen ZJ, et al. Effect of etomidate vs propofol for total intravenous anesthesia on major postoperative complications in older patients: a randomized clinical trial[J]. JAMA Surg, 2022, 157(10): 888. DOI: 10.1001/jamasurg.2022.3338.

[21]

依托咪酯临床应用指导意见专家组. 依托咪酯临床应用指导意见 (2023 版)[J]. 国际麻醉学与复苏杂志, 2024, 45(3): 225-232. DOI: 10.3760/cma.j.cn321761-20240118-00985.

[22]

李薇, 杨秀丽, 刘伟钜, 等. 不同剂量磷丙泊酚二钠在老年患者全麻诱导期镇静效果的比较[J]. 临床麻醉学杂志, 2025, 41(3): 229-232. DOI: 10.12089/jca.2025.03.001.

[23]

司悦, 冯嘉琪, 夏莉. 磷丙泊酚二钠用于老年输尿管镜碎石术患者全麻诱导的价值[J]. 河南外科学杂志, 2024, 30(3): 47-49. DOI: 10.16193/j.cnki.hnwk.2024.03.052.

[24]

Zhu HR, Wang ZB, Ding S, et al. Effect of fospropofol disodium on perioperative neurocognitive function in elderly patients undergoing total hip arthroplasty[J]. Drug Des Dev Ther, 2025, 19: 8195-8209. DOI: 10.2147/dDDT.s548597.

[25]

Griffiths SK, Campbell JP. Placental structure, function and drug transfer[J]. Continuing Educ Anaesth Crit Care Pain, 2015, 15(2): 84-89. DOI: 10.1093/bjaceaccp/mku013.

[26]

王梦媛. 磷丙泊酚二钠孕期药代动力学及组织屏障透过研究[D]. 石家庄: 河北医科大学, 2024.

[27]

Zhang B, Zhan ZL, Xi SJ, et al. Alkaline phosphatase of late pregnancy promotes the prediction of adverse birth outcomes[J]. J Glob Health, 2025, 15: 04028. DOI: 10.7189/jogh.15.04028.

[28]

Xu YC, Pan SY, Jiang WX, et al. Effects of propofol on the development of cancer in humans[J]. Cell Prolif, 2020, 53(8): e12867. DOI: 10.1111/cpr.12867.

[29]

何毕晨, 王超, 岳珍, 等. 丙泊酚/磷丙泊酚二钠/七氟烷对小鼠乳腺癌根治术肺转移影响的比较[J]. 中华麻醉学杂志, 2023, 43(9): 1072-1075. DOI: 10.3760/cma.j.cn131073.20230602.00910.

[30]

杨曦仑, 彭潇仪, 冯钰铎, 等. 丙泊酚对围术期缺血性脑卒中的神经保护作用[J]. 河北医药, 2025, 47(5): 828-834. DOI: 10.3969/j.issn.1002-7386.2025.05.027.

[31]

黄清华, 罗朝志. 不同剂量磷丙泊酚钠后处理对大鼠肝脏缺血再灌注损伤的影响[J]. 华西医学, 2013, 28(5): 741-745. DOI: 10.7507/1002-0179.20130229.

[32]

Veilleux C, Boulanger A. Perineal pruritus in epidural dexamethasone injections[J]. Can J Pain, 2019, 3(1): 167-168. DOI: 10.1080/24740527.2019.1650614.

[33]

张未, 付静文, 王永徽, 等. 纳布啡对磷丙泊酚钠全身麻醉后瘙痒/感觉异常影响的研究[J]. 药物不良反应杂志, 2023, 25(6): 327-331. DOI: 10.3760/cma.j.cn114015-20220905-00809.

[34]

Jiao B, Xu XL, Cui Y, et al. Premixed lidocaine with fospropofol disodium for safety and clinical evaluation regarding paresthesia upon fospropofol disodium injection: a preclinical experimental study and a randomized controlled trial[J]. MedComm, 2026, 7(4): e70670. DOI: 10.1002/mco2.70670.

[35]

Yi XQ, Li R, Zhang WS, et al. Effect of single doses of HX0507 on QTc intervals in healthy people: a phase Ⅰ safety and tolerability study[J]. Sichuan Da Xue Xue Bao Yi Xue Ban, 2012, 43(6): 868-872.

[36]

Zou CC, Chen HY, Qiu YH. Clinical use of fospropofol disodium: evaluation of pharmacology, safety, and efficacy[J]. Drug Des Dev Ther, 2025, 19: 5453-5460. DOI: 10.2147/DDDT.S516789.

[37]

Mueller SW, Moore GD, MacLaren R. Fospropofol disodium for procedural sedation: emerging evidence of its value[J]. Clin Med Insights Ther, 2010, 2: 1179559X1000200003. DOI: 10.1177/1179559x1000200003.

基金资助

河北省卫生健康委基金项目(20220579)

AI Summary AI Mindmap
PDF (491KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉